Last reviewed · How we verify
Allogeneic T cell progenitors, cultured ex-vivo
Allogeneic T cell progenitors, cultured ex-vivo is a Biologic drug developed by Smart Immune SAS. It is currently in Phase 1 development. Also known as: SMART101.
At a glance
| Generic name | Allogeneic T cell progenitors, cultured ex-vivo |
|---|---|
| Also known as | SMART101 |
| Sponsor | Smart Immune SAS |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide (PHASE1, PHASE2)
- Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT (PHASE1, PHASE2)
- Ex-vivo Expanded Donor Regulatory T Cells for Prevention of Acute Graft-Versus-Host Disease (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Allogeneic T cell progenitors, cultured ex-vivo CI brief — competitive landscape report
- Allogeneic T cell progenitors, cultured ex-vivo updates RSS · CI watch RSS
- Smart Immune SAS portfolio CI
Frequently asked questions about Allogeneic T cell progenitors, cultured ex-vivo
What is Allogeneic T cell progenitors, cultured ex-vivo?
Allogeneic T cell progenitors, cultured ex-vivo is a Biologic drug developed by Smart Immune SAS.
Who makes Allogeneic T cell progenitors, cultured ex-vivo?
Allogeneic T cell progenitors, cultured ex-vivo is developed by Smart Immune SAS (see full Smart Immune SAS pipeline at /company/smart-immune-sas).
Is Allogeneic T cell progenitors, cultured ex-vivo also known as anything else?
Allogeneic T cell progenitors, cultured ex-vivo is also known as SMART101.
What development phase is Allogeneic T cell progenitors, cultured ex-vivo in?
Allogeneic T cell progenitors, cultured ex-vivo is in Phase 1.
Related
- Manufacturer: Smart Immune SAS — full pipeline
- Also known as: SMART101
- Compare: Allogeneic T cell progenitors, cultured ex-vivo vs similar drugs
- Pricing: Allogeneic T cell progenitors, cultured ex-vivo cost, discount & access